Written by Bureau
Print this
Topics: Movies, Superheroes

Thursday, 31 December 2009

image for Movies in pipeline Of Little Known Superhero, Tampon Man

Of course, everyone has heard of Spiderman, The Incredible Hulk and Iron Man but how many would pay to go see Tampon Man?

That's the question upmost in the minds of executives after purchasing the rights to do movies and products from Superfluous Comics.

Moviegoers have already shown a willingness to be entangled by Spider-Man's web several times over. Now, as producers prepare to make use of the comic-book powerhouse, it faces the question of whether fans will also get attached to characters as obscure as Ant-Man, and their first effort, Tampon Man!

Tampon Man is not a nice teenager at first as he's always drilling peep holes in women's showers. That's until the day there is an explosion in his room with tampons showered upon him from his peep hole position, and he finds he can absorb almost anything, including oil spills!

Movie makers are staking a $4.2 billion bet that they will come to see the movies as it nears completion of its acquisition of the comic house this week. The final deal brings those super characters and thousands of others to an entertainment empire.

But will Tampon Man make it to those heights?

"We think that the very fact that this guy isn't perfect will appeal to many younger people", stated Producer, Lloyd Hardon. "Plus the tale itself is totally absorbing."

Make Bureau's day - give this story five thumbs-up (there's no need to register, the thumbs are just down there!)

The story above is a satire or parody. It is entirely fictitious.

Do you dream of being a comedy news writer? Click here to be a writer!

More by this writer

View Story
View Story
View Story
View Story
View Story
View Story


Mailing List

Get Spoof News in your email inbox!


What's 1 multiplied by 1?

3 4 1 16
83 readers are online right now!

Go to top

We use cookies to give you the best experience, this includes cookies from third party websites and advertisers.

Continue ? Find out more